Genmab — Maj 2015
-
Danmarks bedste biotekanalytiker har nu også øget Exiqons kursmål til 14 DKK: http://www.jyskebank.dk/finansnyt/aktieanbefalinger/aktiedetaljer?cat=JyskeMarkets/EXQ.CO&assetid=EXQ.CO
-
Mon det er et salgssignal?
-
Var det i dag programmet for J&J R&D dagen kom ud ?
-
The agenda for the day will be posted on the Investor Relations website on approximately May 13th.
Investors and other interested parties may access this meeting by visiting the Company's website at www.investor.jnj.com for a simultaneous webcast of the presentations.
-
Så i morgen kommer "agendaen"
-
Fordi DAX = -1 % og genmab har højere beta
-
Det er ulempen ved at vi er blevet et stort selskab. Vi kan ikke leve i vores egen verden mere som vi kunne føre. Nu følger vi markedet i højere grad
-
Hvilket jo også især er fordi en masse indeksfonde nu har genmab
-
Og $ nede 0,8% det giver også lidt negativt. så dax + $ fald = genmab fald i dag ca.

-
Prøv at læs dette brev til sidst: http://investor.sppirx.com/secfiling.cfm?filingid=919574-15-3939&CIK=831547 Endelig en som tør siden sandheden til Raj
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind